Koyfin Home > Directory > Health Care > Akebia Therapeutics > Gross Profit

Akebia Therapeutics Gross Profit Chart (AKBA)

Akebia Therapeutics annual/quarterly Gross Profit from 2015 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Akebia Therapeutics Gross Profit for the quarter ending June 06, 2020 was $16m a 48.58% increase of 8m year over year
  • Akebia Therapeutics Gross Profit for the last 12 months ending June 06, 2020 was $52m a 158.77% increase of 83m year over year
  • Akebia Therapeutics Annual Gross Profit for 2019 was $27m a 419.77% increase of 111m from 2018
  • Akebia Therapeutics Annual Gross Profit for 2018 was $-85m a 41.44% decrease of -35m from 2017
  • Akebia Therapeutics Annual Gross Profit for 2017 was $-50m a -130.04% increase of 65m from 2016
Other Income Statement Metrics:
  • Akebia Therapeutics EBITDA for the quarter ending December 12, 2018 was $-85m a 71.45% decrease of -61m year over year
  • Akebia Therapeutics Net Income for the quarter ending December 12, 2018 was $-88m a 73.50% decrease of -65m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Gross Profit Data

06/2020$16m
03/2020$-1m
12/2019$29m
09/2019$8m
06/2019$6m
03/2019$-18m
12/2018$-29m
09/2018$-17m
06/2018$-23m
03/2018$-15m

Annual AKBA Gross Profit Data

2019$27m
2018$-85m
2017$-50m
2016$-114m
2015$-43m
2014$-23m